Hyflux Ltd Intrinsic Valuation and Fundamental Analysis - Hyflux Ltd

H	Hyflux Ltd SGX:600	SG
	Radiopharm Theranostics Ltd NASDAQ:RADX	AU
B	Bicara Therapeutics Inc NASDAQ:BCAX	US

Intrinsic Value

600 price has not been updated for more than 4 years. This may indicate that the stock has been delisted.

600 latest financial reports are more than 4 years old.

The intrinsic value for Hyflux Ltd (600) under the Base Case is 0.17 SGD. Compared with the current market price of 0.21 SGD, the stock appears Overvalued by 21% .

Intrinsic value calculated using DCF

S$0.17

Do our valuations actually work? See backtest results .

Intrinsic Value

Overvaluation 21%

Intrinsic Value

Price S$0.21

H

Loading...

What is Valuation History?

Track Buy Zone

20% below Intrinsic Value S$0.13

Get notified when the price drops into your buy zone

Current Price S$0.21

Intrinsic Value S$0.17

Margin of Safety 20% S$0.13

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Hyflux Ltd.

Explain Valuation